Therapeutic Advances in Pain Management (TechVision)

 

USD 4,950

* Required Fields

USD 4,950

PAY BY INVOICE

Be the first to review this product

This research service covers key technological trends and developments across global analgesic products and technologies that are likely to have a high impact in the near future. Based on the observation of the global analgesic industry, advances and technological trends across existing and emerging technologies have been detailed. While providing brief overviews of the existing analgesic landscape across prevalent pain disorders, the research service also covers emerging pain disease treatments. Furthermore, the research services encompasses drivers and challenges, market adoption, collaborations, technology road-map and patent analysis for the global analgesic markets.

Table of Contents

1.0 Executive Summary1.1 Scope of Research1.2 Research Methodology1.2 Research Methodology (continued)1.3 Key Findings: Abuse-Deterrent Opioids, Non-Narcotics and Monoclonal Antibodies Are Likely to Emerge as the Preferred Analgesics2.0 Technology Snapshot and Trends2.1 Overview of Pain Disorders2.2 Snapshot of Existing and Emerging Pain Therapies2.3 Key Application Areas for Pain Treatments: Low Back Pain, Migraine and Arthritic Pain Are Some of the Key Application Areas2.4 Treatment of Low Back Pain: A Brief Overview2.5 Stem Cell and Monoclonal Antibody Therapies Are Likely to Emerge as Promising Treatment Options for Low Back Pain2.6 Clinical Management of Migraine: Summary of Existing and Emerging Therapies2.7 Emerging Migraine Therapies: Monoclonal Antibodies Are Emerging as a Promising Drug Class2.8 Arthritic Pain Relief: Overview of Prevalent and Emerging Clinical Management Strategies2.9 Biotherapies Are Likely to Emerge as the Preferred Treatment Alternative for the Management of Arthritic Pain2.10 Overview of Existing and Emerging Treatment Options for Fibromyalgia2.11 Emerging Treatment Options for Fibromyalgia: A Brief Summary 2.12 Clinical Management Strategies for Coping with Cancer Pain2.13 Recent Developments in Cancer Pain Therapy: Novel Opioid Formulations on the Rise2.14 Overview of Neuropathic Pain Medications2.15 Emerging Therapies for Neuropathic Pain: A Brief Summary2.16 Treatment Strategies for Post-Operative Pain2.17 Recent Advances across Post-Operative Pain Therapies2.18 Timeline Overview for US FDA Approved Analgesics2.19 Non-Narcotics Dominate the Analgesic Pipeline3.0 Impact Analysis and Assessment3.1 Therapeutic Hotspots for Pain Disorders3.2 Key Market Drivers and Challenges across the Global Analgesics Markets3.3 Increasing Demand for Non-Narcotic Medications is Likely to Fuel Market Growth for Analgesics3.4 Global Analgesic Markets Need to Address Pain Assessment and Reimbursement Challenges 4.0 Strategic Insights4.1 Overview of the Collaborative Landscape4.2 Big Pharma Partnerships Fuel New Product Developments4.3 Key Product Development Collaborations for Pain Management4.4 Key Research and Development Collaborations across the Global Analgesics Market4.5 Licensing and Marketing Collaborations in the Pain Management Industry4.6 Global Adoption Scenario5.0 Emerging Opportunities and Conclusion5.1 Technology Roadmap for the Global Pain Management Sector5.2 Key Conclusions for the Global Analgesics Market6.0 Patent Analysis6.1 Patent Search Scope6.2 Patent Publishing Trends6.3 Leading Patent Holders6.4 Leading Patent Offices6.5 Key Patents Related to Analgesics – Non-Opioid & Opioid Therapies6.6 Key Patents Related to Analgesics – Antibody TherapiesLegal Disclaimer7.0 Appendix and Key Contacts7.1 Advances in Musculoskeletal and Back Pain Therapy7.2 Key Contacts 7.2 Key Contacts (continued)8.0 The Frost & Sullivan Story8.1 The Frost & Sullivan Story8.2 Value Proposition: Future of Your Company & Career8.3 Global Perspective8.4 Industry Convergence8.5 360º Research Perspective8.6 Implementation Excellence8.7 Our Blue Ocean Strategy




Related Research

Release Date : 19-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Release Date : 12-May-17

Region : Global

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.